Intellectual Property
-
Patents related to Amgen Inc.’s cholesterol-lowering drug Repatha survived a challenge by rival pharmaceutical company Sanofi when a Delaware federal jury found largely in Amgen’s favor Monday… Read this piece in its entirety at Law360.
-
California Attorney General Xavier Becerra and state Sen. Hannah-Beth Jackson announced a bill Monday that they said would make several fixes to the California Consumer Privacy Act, the latest move to modify the landmark law passed in 2018… Read this piece in its entirety at Law360.
-
A China-linked nutritional supplement maker hijacked the trademarked design of a Florida company’s “Sugar Bear Hair” gummy vitamins, according to a lawsuit filed Monday in Sunshine State federal court… Read this piece in its entirety at Law360.
-
The estate of Massimo Vignelli and his wife accused one of the late Italian designer’s former employees of publishing a book that uses Vignelli’s name and work without permission, according to a lawsuit filed Wednesday in New York federal court… Read this piece in its entirety at Law360.
-
The America Invents Act doesn’t stop patent challengers who won at the Patent Trial and Appeal Board from pursuing their winning arguments in court, and blocking that judicial path would lead to “absurd results,” a group of generic-drug makers told the Federal Circuit on Tuesday… Read this piece in its entirety at Law360.
Mike LaSusa 